Red blood cell membrane-coated functionalized Cu-doped metal organic framework nanoformulations as a biomimetic platform for improved chemo-/chemodynamic/photothermal synergistic therapy

Luping Ren,Yanfang Sun,Junhao Zhang,Lei Nie,Amin Shavandi,Khaydar E Yunusov,Uladzislau E Aharodnikau,Sergey O Solomevich,Guohua Jiang,Khaydar E. Yunusov,Uladzislau E. Aharodnikau,Sergey O. Solomevich

DOI: https://doi.org/10.1016/j.ijpharm.2024.123811

IF: 6.51

2024-01-18

International Journal of Pharmaceutics

Abstract:Nanoformulations for combining chemotherapy, chemodynamic therapy, and photothermal therapy have enormous potential in tumor treatment. Coating nanoformulations with cell membranes endows them with homologous cellular mimicry, enabling nanoformulations to acquire new functions and properties, including homologous targeting and long circulation in vivo , and can enhance internalization by homologous cancer cells. Herein, we fused multifunctional biomimetic nanoformulations based on Cu-doped zeolitic imidazolate framework-8 (ZIF-8). Hydroxycamptothecin (HCPT), a clinical anti-tumor drug, was encapsulated into ZIF-8, which was subsequently coated with polydopamine (PDA) and red blood cell membrane. The as-fabricated biomimetic nanoformulations showed an enhanced cell uptake in vitro and the potential to prolong blood circulation in vivo , producing effective synergistic chemotherapy, chemodynamic therapy, and photothermal therapy under the 808 nm laser irradiation. Together, the biomimetic nanoformulations showed a prolonged blood circulation and evasion of immune recognition in vivo to provide a bio-inspired strategy which may have the potential for the multi-synergistic therapy of breast cancer.

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper aims to address the challenges posed by traditional methods in breast cancer treatment (such as surgical resection, chemotherapy, and radiotherapy), including high tumor recurrence rates, damage to normal cell function, and the emergence of multidrug resistance. To overcome these limitations and improve the effectiveness of breast cancer treatment, the research team developed a multifunctional biomimetic nanodrug delivery system based on copper-doped metal-organic frameworks (Cu-doped ZIF-8).

Specifically, the system is implemented through the following steps:
1. **Preparation of Cu-ZIF-8 nanoparticles**: Synthesis of Cu-ZIF-8 nanoparticles with a dodecahedral structure through an ion doping strategy.
2. **Loading of anticancer drugs**: Encapsulation of the clinical antitumor drug hydroxycamptothecin (HCPT) into Cu-ZIF-8 to form HCuZ nanoparticles.
3. **Introduction of polydopamine coating**: Coating the surface of HCuZ with polydopamine (PDA) to form HCuZP composite nanoparticles, enhancing their photothermal properties.
4. **Red blood cell membrane coating**: Finally, wrapping HCuZP nanoparticles with red blood cell membranes to form Rm-HCuZP composite nanoparticles, improving immune evasion capability and prolonging blood circulation time.

This system can generate a photothermal effect under near-infrared light irradiation and promote the synergistic effects of chemotherapy, chemodynamic therapy, and photothermal therapy, thereby effectively treating breast cancer. Additionally, the red blood cell membrane coating enhances the biocompatibility and targeting ability of the nanoparticles.